Guest: Reginald C. W. Bell, MD, FACS

Dr. Reginald C.W. Bell recently presented at a live meeting that there is Level I and Level II evidence of durable control of regurgitation and atypical symptoms that can be achieved in specially selected population of GERD patients, which are patients partially responsive to PPIs and have a small hiatal hernia and good motility. In well-selected patients, TIF is a proven endoscopic alternative to other GERD therapies. With appropriate training and education, clinicians can ensure that the TIF procedure is done to obtain optimal outcomes. Dr. Bell is founder of the SurgOne Foregut Institute. For additional clinical data, please visit EndoGastric Solutions at http://www.endogastricsolutions.com/data/